0000950170-24-082739.txt : 20240710 0000950170-24-082739.hdr.sgml : 20240710 20240710164740 ACCESSION NUMBER: 0000950170-24-082739 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240708 ITEM INFORMATION: Unregistered Sales of Equity Securities FILED AS OF DATE: 20240710 DATE AS OF CHANGE: 20240710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 241110412 BUSINESS ADDRESS: STREET 1: 19800 MACARTHUR BLVD. STREET 2: SUITE 250 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19800 MACARTHUR BLVD. STREET 2: SUITE 250 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Novus Therapeutics, Inc. DATE OF NAME CHANGE: 20170511 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 8-K 1 eldn-20240708.htm 8-K 8-K
0001404281false00014042812024-07-082024-07-08

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 08, 2024

 

 

Eledon Pharmaceuticals, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-36620

20-1000967

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

19800 MacArthur Blvd.

Suite 250

 

Irvine, California

 

92612

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 949 238-8090

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.001 par value

 

ELDN

 

Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 3.02 Unregistered Sales of Equity Securities.

On July 8, 2024, Eledon Pharmaceuticals, Inc. (the “Company”) completed the sale of 909,088 shares of its common stock, $0.001 par value per share, pursuant to a second closing contemplated under the Securities Purchase Agreement, dated April 28, 2023, by and among the Company and certain institutional and accredited investors. The sale resulted in gross proceeds to the Company of approximately $2.1 million. The shares were sold pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act of 1933, as amended, and Rule 506(b) promulgated thereunder.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Eledon Pharmaceuticals, Inc.

 

 

 

 

Date:

July 10, 2024

By:

/s/ David-Alexandre C. Gros, M.D.

 

 

 

Name: David-Alexandre C. Gros, M.D.
Title: Chief Executive Officer

 

 EX-101.SCH 2 eldn-20240708.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Document And Entity Information
Jul. 08, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 08, 2024
Entity Registrant Name Eledon Pharmaceuticals, Inc.
Entity Central Index Key 0001404281
Entity Emerging Growth Company false
Entity File Number 001-36620
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 20-1000967
Entity Address, Address Line One 19800 MacArthur Blvd.
Entity Address, Address Line Two Suite 250
Entity Address, City or Town Irvine
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92612
City Area Code 949
Local Phone Number 238-8090
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value
Trading Symbol ELDN
Security Exchange Name NASDAQ
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports eldn-20240708.htm eldn-20240708.xsd http://xbrl.sec.gov/dei/2024 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "eldn-20240708.htm": { "nsprefix": "eldn", "nsuri": "http://www.eledon.com/20240708", "dts": { "inline": { "local": [ "eldn-20240708.htm" ] }, "schema": { "local": [ "eldn-20240708.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 23 }, "report": { "R1": { "role": "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_1665c3ac-ccdb-4a7d-a7df-622a71698d1f", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "eldn-20240708.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_1665c3ac-ccdb-4a7d-a7df-622a71698d1f", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "eldn-20240708.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.eledon.com/20240708/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 12 0000950170-24-082739-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-082739-xbrl.zip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eldn-20240708_htm.xml IDEA: XBRL DOCUMENT 0001404281 2024-07-08 2024-07-08 0001404281 false 8-K 2024-07-08 Eledon Pharmaceuticals, Inc. DE 001-36620 20-1000967 19800 MacArthur Blvd. Suite 250 Irvine CA 92612 949 238-8090 false false false false Common Stock, $0.001 par value ELDN NASDAQ false